Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global colorectal cancer diagnostics market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Test type trends
2.4 End-use trends
Chapter 3 Colorectal Cancer Diagnostics Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increasing incidence and prevalence of colorectal cancer
3.5.1.2 Government initiatives and policies associated with cancer screening tests
3.5.1.3 Technological advancements in field of cancer diagnostics
3.5.1.4 Growing awareness regarding early diagnosis
3.5.2 Industry pitfalls & challenges
3.5.2.1 High cost of diagnostic tests and procedures
3.5.2.2 Lack of reimbursement policies for diagnostic tests
3.6 Growth potential analysis
3.6.1 By test type
3.6.2 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive analysis of major market players, 2022
4.2.1 Abbott Laboratories
4.2.2 BioMerieux SA
4.2.3 Becton, Dickinson, and Company
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Colorectal Cancer Diagnostics Market Size and Forecast, By Test Type, 2018-2032 (USD Million)
5.1 Key trends, by test type
5.2 Blood test
5.3 Stool tests
5.3.1 Fecal occult blood test (FOBT)
5.3.2 Fecal biomarker test
5.3.3 CRC DNA screening test
5.4 Imaging test
5.4.1 Computed tomography (CT) scan
5.4.2 Ultrasound
5.4.3 Magnetic resonance imaging (MRI) scan
5.4.4 Positron emission tomography (PET) scan
5.4.5 Colonoscopy
5.4.6 Other imaging tests
5.5 Biopsy
5.6 Other test types
Chapter 6 Colorectal Cancer Diagnostics Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic Imaging Centers
6.4 Cancer Research Centers
6.5 Others end-users
Chapter 7 Colorectal Cancer Diagnostics Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pcific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 BioMerieux SA
8.3 Becton, Dickinson and Company
8.4 GE Healthcare
8.5 Qiagen N.V
8.6 F-Hoffmann-La Roche Ltd
8.7 Siemens Healthineers
8.8 Sysmex Corporation
8.9 Thermo Fischer Scientific
8.10 Hologic Inc
8.11 Epigenomics AG
